Trial at 36 Months: 37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose groups with 95% of patients off all topical IOP-lowering drops100% of evaluable patients ...

SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...

Battie can already grab and go in transition and play a face-up option to exploit mismatches in the half-court. For example, ...

BioCardia (BCDA) announced the first patient enrolled at Henry Ford Health in its ongoing Phase 3 CardiAMP HF II clinical trial for patients with ...

The Central Government had approved the JP Nagar 4th Phase–Kempapura route nearly a year ago, but tenders were delayed, ...

In what experts are calling a breakthrough in the global fight against malaria, a new next-generation drug candidate — GanLum (ganaplacide/lumefantrine, KLU156) — has shown a 97% cure rate in Phase 3 ...

The Election Commission of India (ECI) said on Tuesday that Bihar registered an overall voter turnout of 66.91 per cent, its ...

BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the first patient enrolled at ...

Belgium’s Tihange Nuclear Power Plant unit 3 will have its control rod system modernised over several years after Framatome ...

BMRCL to invite tenders for Namma Metro Phase 3, a ₹9,700-crore double-decker project connecting JP Nagar to Hebbal. The 28.4-km corridor marks a major step in Bengaluru’s metro expansion after months ...

1. Willi R, Bril V, Howard J, et al. RELIEVE: a phase 3 study evaluating the efficacy and safety of remibrutinb in generalized myasthenia gravis. Presented at: American Association of Neuromuscular & ...